terramycin/la vet 200 mg/ml injektioneste, liuos
zoetis animal health aps - oxytetracycline dihydrate - injektioneste, liuos - 200 mg/ml - oksitetrasykliini
drontal vet. 230 mg / 20 mg tabletti, kalvopäällysteinen
vetoquinol s.a. - praziquantel, pyrantel embonate - tabletti, kalvopäällysteinen - 230 mg / 20 mg - pratsikvanteeli
baymite vet. 500 mg/ml konsentraatti sumutetta varten, emulsio
bayer animal health gmbh - phoxim - konsentraatti sumutetta varten, emulsio - 500 mg/ml - foksiimi
humulin nph kwikpen 100 iu/ml injektioneste, suspensio, esitäytetty kynä
eli lilly finland oy ab - isophane insulin human - injektioneste, suspensio, esitäytetty kynä - 100 iu/ml - ihmisinsuliini
camasan vet 380/60/50 mg/ml infuusioneste, liuos
interchemie werken de adelaar eesti as - boric acid, calcium gluconate ad iniectabile, magnesium chloride hexahydrate - infuusioneste, liuos - 380/60/50 mg/ml - kalsiumin yhdistelmävalmisteet d-vitamiinin ja/tai muiden lääkeaineiden kanssa
nerfasin vet 20 mg/ml injektioneste, liuos
le vet. b.v. - xylazine hydrochloride - injektioneste, liuos - 20 mg/ml - ksylatsiini
xysol vet. 20 mg/ml injektioneste, liuos
cp-pharma handelsgesellschaft mbh - xylazine hydrochloride - injektioneste, liuos - 20 mg/ml - ksylatsiini
sefazin vet 20 mg/ml injektioneste, liuos
interchemie werken de adelaar eesti as - xylazine hydrochloride - injektioneste, liuos - 20 mg/ml - ksylatsiini
airexar spiromax
teva b.v. - salmeterol fluticasone propionate - pulmonary disease, chronic obstructive; asthma - obstruktiivisten hengitystiesairauksien lääkkeet, - airexar spiromax on tarkoitettu käytettäväksi vain 18-vuotiailla ja sitä vanhemmilla aikuisilla. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. krooninen obstruktiivinen keuhkosairaus (copd)airexar spiromax on tarkoitettu oireenmukaiseen hoitoon potilailla, joilla on copd, fev1.
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - obstruktiivisten hengitystiesairauksien lääkkeet, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).